Open-Label Bendamustine for Pediatric Patients with Relapsed or Refractory Acute Leukemia: Safety and Efficacy Outcomes

• Published in: Blood Vol. 118; no. 21; p. 3602
• Main Authors: Fraser, Christopher, Brown, Patrick A., Megason, Gail C., Ahn, Hyo Seop, Cho, Bin, Kirov, Ivan I., Frankel, Lawrence S., Aplenc, Richard, Bensen-Kennedy, Debra M., Munteanu, Mihaela C., Weaver, Jennifer, Harker-Murray, Paul
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 18.11.2011

Abstract 3602 Acute leukemias, consisting of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), are the most common form of childhood cancers. New treatments are needed for patients whose disease progresses or recurs following established therapies. Bendamustine is an alkylating ag...